Value of FDG-PET/CT examinations in different cancers of children, focusing on lymphomas

Edit Bárdi, Mónika Csóka, Ildikó Garai, István Szegedi, Judit Müller, Tamás Györke, Kornélia Kajáry, Karolina Nemes, Csongor Kiss, Gábor Kovács

Research output: Article

6 Citations (Scopus)

Abstract

The aim of the study was to assess sensitivity and specificity of FDG-PET/CT in different forms of childhood cancer. We retrospectively evaluated the results dedicated of 162 FDG-PET/CT examinations of 86 children treated with: Hodgkin lymphoma (HL; n=31), non-Hodgkin lymphoma (NHL; n=30) and other high grade solid tumors (n=25). Patients were admitted and treated in two departments of pediatric hematology and oncology in Hungary. FDG-PET/CT was performed for staging (n=25) and for posttreatment evaluation (n=137). Imaging was performed in three FDG-PET/CT Laboratories, using dedicated PET/CT scanners. False positive results were defined as resolution or absence of disease progression over at least 1 year on FDG-PET/CTscans without any intervention. In some cases histopathological evaluation of suspicious lesions was performed. Fals negative results were defined as negative FDG-PET/CT results in case of active malignancy. Positive predictive values (PPV) and negative predictive values (NPV) were calculated. NPV was 100%. The highest PPV was observed in high grade solid tumors (81%), followed by HL (65%) and NHL (61%). There was a major difference of PPV in different histological types of HL (50% in HL of mixed-cellularity subtype, 90% in nodular sclerosing, and 100% in lymphocyte-rich and lymphocyte depleted HL). We treated one patient with nodular lymphocyte predominant HL, who had 5 false positive FDG-PET/CT results. PPV of T-and B-lineage NHL were similar (60%and 62%, respectively). We observed an interesting difference of PPV in different stages of HL and NHL. In HL PPV was higher in early than in advanced disease forms: 66% in stage II HL and 60% in stage III HL, whereas there was an inverse relationship between PPV and disease stages in NHL 0%in stage I and II patients, 67% in stage III and 100% in stage IV patients. PPV was lower in males (54%) than in females (65%). PPV were 64% vs. 58% in patients under vs. over 10 years of age. Negative FDG-PET/CT results during follow-up reliably predict the absence of malignancy. Positive FDG-PET/CT scan results in general have a low PPV. The relatively high PPV in patients with histologically proven high grade solid tumors, advanced stages of NHL and with nodular sclerosing, lymphocyte-rich and lymphocyte depleted subtypes of HL warrant a confirmation by biopsy, whereas the watch-and-wait approach can be used in other forms of childhood cancer patients with a positive FDG-PET/CT result in course of follow-up examinations.

Original languageEnglish
Pages (from-to)139-143
Number of pages5
JournalPathology and Oncology Research
Volume20
Issue number1
DOIs
Publication statusPublished - jan. 2014

    Fingerprint

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Cite this

Bárdi, E., Csóka, M., Garai, I., Szegedi, I., Müller, J., Györke, T., Kajáry, K., Nemes, K., Kiss, C., & Kovács, G. (2014). Value of FDG-PET/CT examinations in different cancers of children, focusing on lymphomas. Pathology and Oncology Research, 20(1), 139-143. https://doi.org/10.1007/s12253-013-9676-3